All stories12
Showing 7–12 / 12
CreatiPhage Completes Pre-A Financing, Accelerating the Commercialization of Phage Therapy
Recently, CreatiPhage (Shanghai) Biotechnology Co., Ltd. (referred to as "CreatiPhage") announced the completion of its Pre-A round of financing, exclusively invested by Xuhui Science and Technology Investment Private Fund…
Read story
CreatiPhage's 2023 Highlights
01 we valued interaction with the public releasing official promotional videos with CreatiPhage holding design contests with CreatiPhage launching the ChatPhage Forum CreatiPhage establishing a “100 Questions” column 02 we…
Read story
Minhang biotech company leading the charge against antibiotic resistance
By Li Xinyi, Yang Yang. A biotech company in Minhang District's Xinzhuang Industrial Zone is trying to tackle antibiotic resistance by tapping the potential of bacteriophage (also known as phage, a group of viruses that infect…
Read story
CreatiPhage Great Achievement at the 2023 Maker in China Shanghai Competition
Recently, the 2023 Maker in China SME (Small Medium Enterprise) Innovation and Entrepreneurship Competition in Shanghai concluded. CreatiPhage participating for the first time, achieved remarkable results by winning the first…
Read story
CreatiPhage Recognized as Shanghai's Innovative SME
On September 21, 2023, following the “Shanghai Quality SME Gradient Cultivation Management Implementation Rules” (Shanghai Economic and Information Regulation [2022] No.8), the Shanghai Municipal Commission of Economy and…
Read story
Jiahui Health Partners with CreatiPhage to Advance Clinical Translation of Phage Therapy
Shanghai, June 29, 2022 /PRNewswire/ -- Research and clinical applications of bacteriophages (phage) have spanned over a century, contributing revolutionary biotechnological tools such as T4 ligase and the CRISPR system while…
Read story